Phillylacrosse.com, Posted 12/14/12
The Haverford School is proud to host the Fifth Annual Nike “Checking for Cancer” Lacrosse Invitational, featuring top nationally ranked boys’ lacrosse programs and girls’ lacrosse programs.
The event – which raises money as well as awareness for three cancers (prostate, testicular and colon) especially affecting males – will be held on April 13, 2013 at Haverford.
The star-studded field will feature four or five boys’ games and four girls’ games. In the next week it should be determined if a fifth boys’ game will be held.
The boys’ matchups include:
Haverford School, PA (2011 national champ, 4-time Inter-Ac League champion, No. 8 in Inside Lacrosse final 2012 poll) vs Salisbury School, CT (ranked No. 6 by Inside Lacrosse)
Chatham, N.J. (state Group 2 champ) vs Brunswick School (CT)
St. Augustine Prep, N.J. (Group A semifinalist) vs La Costa Canyon, CA (22-1, Ranked No. 20 by IL)
Penn Charter, PA vs Salesianum School, DE (2-time state champion)
The girls’ matchups (all PA teams) include:
Merion Mercy Academy (4-time Catholic Academies champion) vs. Downingtown East (2011 PIAA runner-up)
Harriton (state quarterfinalist) vs. Notre Dame (Inter-Ac co-champion)
Agnes Irwin vs. Germantown Friends (Friends League finalist)
Baldwin School vs. The Hill School
The event was created by two renowned lacrosse coaches – Haverford School’s John Nostrant and Georgetown Prep coach Kevin Giblin.
Nostrant, an Eastern PA Chapter of the US Lacrosse Hall of Fame inductee, was diagnosed with prostate cancer 6 years ago and remains cancer-free. Giblin is cancer free after being diagnosed with colon cancer four years ago. Nostrant and Giblin were roommates in college and line mates on the lacrosse field as players at Washington College.
They remain the best of friends. Both highly acclaimed coaches helped coach the United States U-19 Men’s Team to the International World Federation Championship in British Columbia in 2008. Each, however, has had to quietly but courageously endure private ordeals that are all too common to the thousands of individuals who are diagnosed with cancer each year.
